The p53 family in hepatocellular carcinoma

被引：24
作者：
Kunst, Claudia [1 ]
Haderer, Marika [1 ]
Heckel, Sebastian [1 ]
Schlosser, Sophie [1 ]
Mueller, Martina [1 ]
机构：
[1] Univ Hosp Regensburg, Dept Internal Med 1, Franz Josef Str Allee 11, D-93053 Regensburg, Germany
来源：
TRANSLATIONAL CANCER RESEARCH | 2016年 / 5卷 / 06期
关键词：
MUTANT P53; GENE; TP53; ACTIVATION; CELLS; MDM2; INHIBITOR; APOPTOSIS; ONCOGENE; MEDIATOR;
D O I：
10.21037/tcr.2016.11.79
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：632 / 638
页数：7
相关论文
共 50 条
  • [1] Interference with the p53 family network contributes to the gain of oncogenic function of mutant p53 in hepatocellular carcinoma
    Schilling, Tobias
    Kairat, Astrid
    Melino, Gerry
    Krammer, Peter H.
    Stremmel, Wolfgang
    Oren, Moshe
    Mueller, Martina
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 394 (03) : 817 - 823
  • [2] Apoptosis, PCNA and p53 in hepatocellular carcinoma
    Paiva, C
    Oshima, CTF
    Lanzoni, VP
    Forones, NM
    HEPATO-GASTROENTEROLOGY, 2002, 49 (46) : 1058 - 1061
  • [3] The p53 Family of Transcription Factors Represses the Alpha- fetoprotein Gene Expression in Hepatocellular Carcinoma
    Woelfel, Gisela
    Ostheim, Elisabeth
    Staub, Agnes
    Tuemen, Deniz
    Heumann, Philipp
    Schmid, Stephan
    Schlosser, Sophie
    Mueller, Martina
    Guelow, Karsten
    Kunst, Claudia
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2023, 32 (03) : 346 - 355
  • [4] Analysis of p53 Protein Expression in Hepatocellular Carcinoma
    Graur, Florin
    Furcea, Luminita
    Mois, Emil
    Biliuta, Andrei
    Rozs, Aliz-Timea
    Negrean, Vasile
    Al Hajjar, Nadim
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2016, 25 (03) : 345 - 349
  • [5] p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis
    Jia, Shuting
    Tang, Wenru
    Luo, Ying
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 669 - 675
  • [6] AFLATOXIN AND P53 ABNORMALITY IN DUCK HEPATOCELLULAR-CARCINOMA
    IMAZEKI, F
    YOKOSUKA, O
    OHTO, M
    OMATA, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1995, 10 (06) : 646 - 649
  • [7] ARID2, p110α, p53, and β-catenin protein expression in hepatocellular carcinoma and dinicopathologic implications
    You, Jason
    Yang, Hushan
    Lai, Yinzhi
    Simon, Lindsay
    Au, Jen
    Burkart, Ashlie L.
    HUMAN PATHOLOGY, 2015, 46 (04) : 583 - 592
  • [8] Notch1 Differentially Regulates Oncogenesis by Wildtype p53 Overexpression and p53 Mutation in Grade III Hepatocellular Carcinoma
    Lim, Seung-Oe
    Park, Young Min
    Kim, Hyeon Seop
    Quan, Xiaoyuan
    Yoo, Jeong Eun
    Park, Young Nyun
    Choi, Gi Hong
    Jung, Guhung
    HEPATOLOGY, 2011, 53 (04) : 1352 - 1362
  • [9] Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression
    Hao, Pei-Pei
    Li, Hua
    Lee, Mi-Jin
    Wang, Yun-Peng
    Kim, Jong-Hyun
    Yu, Goung-Ran
    Lee, Sang-Yeop
    Leem, Sun-Hee
    Jang, Kyu-Yun
    Kim, Dae-Ghon
    JOURNAL OF HEPATOLOGY, 2015, 62 (06) : 1278 - 1286
  • [10] LOSS OF HETEROZYGOSITY AND ANALYSIS OF MUTATION OF P53 IN HEPATOCELLULAR-CARCINOMA
    YUMOTO, Y
    HANAFUSA, T
    HADA, H
    MORITA, T
    OOGUCHI, S
    SHINJI, N
    MITANI, T
    HAMAYA, K
    KOIDE, N
    TSUJI, T
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1995, 10 (02) : 179 - 185
12345